Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Paul Leece, Jeremi ...

Cantor Fitzgerald analyst Brett Knoblauch reiterated a Buy rating on TeraWulf Inc (WULF – Research Report) yesterday and set a price target of ...

The stock market is taking a breather after a relentless run, but opportunities still abound, according to some on Wall ...

Rivian Automotive, Inc (NASDAQ:RIVN) stock traded lower Monday. On Friday, the electric vehicle startup reported 14,183 ...

Rivian Automotive (NASDAQ:RIVN – Get Free Report)‘s stock had its “overweight” rating reissued by equities research analysts ...

Equities research analysts at Cantor Fitzgerald initiated coverage on shares of Supernus Pharmaceuticals (NASDAQ:SUPN – Get Free Report) in a research report issued to clients and investors on Monday, ...

US RMBS is set to brush off any concerns that Donald Trump taking office later in the month may cause volatility, with the ...

Goldman has recently initiated Esperion Therapeutics Inc (ESPR) stock to Neutral rating, as announced on December 18, 2024, according to Finviz. Earlier, on December 17, 2024, Cantor Fitzgerald had ...

Ladenburg Thalmann has recently reduced SoundHound AI Inc (SOUN) stock to Neutral rating, as announced on November 13, 2024, according to Finviz. Earlier, on August 9, 2024, Cantor Fitzgerald had ...

Cantor Fitzgerald analyst Kristen Kluska maintained a Buy rating on 89bio (ETNB – Research Report) today and set a price target of $29.00. The ...

The Securities and Exchange Commission (SEC) on Thursday charged Cantor Fitzgerald L.P., a global financial services firm headed by one ...

Cantor Fitzgerald raised the firm’s price target on Axsome Therapeutics (AXSM) to $124 from $121 and keeps an Overweight rating on the shares after the company announced results from the Phase 3 ...